SIGA 📈 SIGA Technologies - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8269171067
SIGA: Antiviral, Smallpox, Treatment, Medicine, Pharmaceuticals
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York. Web URL: https://www.siga.com
Additional Sources for SIGA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SIGA Stock Overview
| Market Cap in USD | 504m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| GiC Sub-Industry | Pharmaceuticals |
| IPO / Inception | 1997-09-09 |
SIGA Stock Ratings
| Growth 5y | 30.6% |
| Fundamental | 72.2% |
| Dividend | 74.3% |
| Rel. Strength Industry | 560 |
| Analysts | - |
| Fair Price Momentum | 6.09 USD |
| Fair Price DCF | 25.90 USD |
SIGA Dividends
| Dividend Yield 12m | 10.15% |
| Yield on Cost 5y | 15.54% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 98.3% |
SIGA Growth Ratios
| Growth Correlation 3m | -36.6% |
| Growth Correlation 12m | 24.9% |
| Growth Correlation 5y | 37.6% |
| CAGR 5y | 8.89% |
| CAGR/Mean DD 5y | 0.22 |
| Sharpe Ratio 12m | 0.48 |
| Alpha | -8.97 |
| Beta | 0.73 |
| Volatility | 51.41% |
| Current Volume | 541k |
| Average Volume 20d | 567.4k |
What is the price of SIGA stocks?
As of December 22, 2024, the stock is trading at USD 5.91 with a total of 540,961 shares traded.
Over the past week, the price has changed by -1.95%, over one month by -3.67%, over three months by -29.31% and over the past year by +15.39%.
As of December 22, 2024, the stock is trading at USD 5.91 with a total of 540,961 shares traded.
Over the past week, the price has changed by -1.95%, over one month by -3.67%, over three months by -29.31% and over the past year by +15.39%.
Is SIGA Technologies a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, SIGA Technologies (NASDAQ:SIGA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 72.16 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SIGA as of December 2024 is 6.09. This means that SIGA is currently overvalued and has a potential downside of 3.05%.
Yes, based on ValueRay Fundamental Analyses, SIGA Technologies (NASDAQ:SIGA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 72.16 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SIGA as of December 2024 is 6.09. This means that SIGA is currently overvalued and has a potential downside of 3.05%.
Is SIGA a buy, sell or hold?
SIGA Technologies has no consensus analysts rating.
SIGA Technologies has no consensus analysts rating.
What are the forecast for SIGA stock price target?
According to ValueRays Forecast Model, SIGA SIGA Technologies will be worth about 6.7 in December 2025. The stock is currently trading at 5.91. This means that the stock has a potential upside of +13.54%.
According to ValueRays Forecast Model, SIGA SIGA Technologies will be worth about 6.7 in December 2025. The stock is currently trading at 5.91. This means that the stock has a potential upside of +13.54%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 17.5 | 196.6% |
| Analysts Target Price | 17.7 | 199.5% |
| ValueRay Target Price | 6.7 | 13.5% |